AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback
In This Article:
AbbVie stock popped Friday after an analyst upgraded it on the remaining opportunity for its Cerevel takeover despite a huge misstep.
Oops, something went wrong
AbbVie stock popped Friday after an analyst upgraded it on the remaining opportunity for its Cerevel takeover despite a huge misstep.